Authors:
SPANIK S
STUDENA M
SYKORA J
KUNOVA A
TRUPL J
PICHNA P
DEMITROVICOVA A
KRALOVICOVA K
GREY E
KUKUCKOVA E
KOREN P
KRCMERY V
Citation: S. Spanik et al., IMPACT OF OFLOXACIN USED PROPHYLACTICALLY IN NEUTROPENIC PATIENTS ON DEVELOPMENT OF RESISTANCE, Infectious diseases in clinical practice, 7(4), 1998, pp. 199-202
Authors:
SPANIK S
SUFLIARSKY J
MARDIAK J
SORKOVSKA D
TRUPL J
KUNOVA A
KUKUCKOVA E
RUSNAKOVA V
DEMITROVICOVA A
PICHNA P
KRUPOVA I
KRALOVICOVA K
MATEICKA F
WEST D
KRCMERY V
Citation: S. Spanik et al., PREDICTORS OF MORTALITY IN BACTEREMIC CANCER-PATIENTS - RETROSPECTIVEANALYSIS OF 64 DEATHS OCCURRING AMONG 262 BACTEREMIC EPISODES, Supportive care in cancer, 6(3), 1998, pp. 291-294
Authors:
KRCMERY V
ORAVCOVA E
SPANIK S
MRAZOVASTUDENA M
TRUPL J
KUNOVA A
STOPKOVAGREY K
KUKUCKOVA E
KRUPOVA I
DEMITROVICOVA A
KRALOVICOVA K
Citation: V. Krcmery et al., NOSOCOMIAL BREAKTHROUGH FUNGEMIA DURING ANTIFUNGAL PROPHYLAXIS OR EMPIRICAL ANTIFUNGAL THERAPY IN 41 CANCER-PATIENTS RECEIVING ANTINEOPLASTIC CHEMOTHERAPY - ANALYSIS OF ETIOLOGY RISK-FACTORS AND OUTCOME, Journal of antimicrobial chemotherapy, 41(3), 1998, pp. 373-380
Authors:
NOVOTNY J
KRALOVICOVA K
KREMERY V
SPANIK S
HALKO J
NETRIOVA J
STUDENAMRAZOVA M
GRAUSOVA S
KOREN P
KRUPOVA Y
DEMITROVICOVA A
KUKUCKOVA E
Citation: J. Novotny et al., IS ROUTINE DRUG-MONITORING OF VANCOMYCIN SERUM LEVELS NEEDED, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4714-4714
Authors:
KRALOVICOVA K
SPANIK S
HALKO J
NETRIOVA J
STUDENAMRAZOVA M
NOVOTNY J
GRAUSOVA S
KOREN P
KRUPOVA I
DEMITROVICOVA A
KUKUCKOVA E
KRCMERY V
Citation: K. Kralovicova et al., DO VANCOMYCIN SERUM LEVELS PREDICT FAILURES OF VANCOMYCIN THERAPY OR NEPHROTOXICITY IN CANCER-PATIENTS, Journal of chemotherapy, 9(6), 1997, pp. 420-426
Authors:
KRCMERY V
SPANIK S
STOPKOVA K
GRAUSOVA S
MARDIAK J
KOREN P
SEPESI J
PECHAN J
DEMITROVICOVA A
KRALOVICOVA K
NOVOTNY J
Citation: V. Krcmery et al., BACTEREMIA IN CANCER-PATIENTS WITH SOLID TUMORS UNDERGOING CHEMOTHERAPY VERSUS SURGERY - RISK-FACTORS, ETIOLOGY AND OUTCOME IN 276 PATIENTS, Journal of chemotherapy, 9(3), 1997, pp. 232-237
Authors:
KUNOVA A
TRUPL J
DEMITROVICOVA A
JESENSKA Z
GRAUSOVA S
GREY E
PICHNA P
KRALOVICOVA K
SORKOVSKA D
KRUPOVA I
SPANIK S
STUDENA M
KOREN P
KRCMERY V
Citation: A. Kunova et al., 8-YEAR SURVEILLANCE OF NON-ALBICANS CANDIDA SPP IN AN ONCOLOGY-DEPARTMENT PRIOR TO AND AFTER FLUCONAZOLE HAD BEEN INTRODUCED INTO ANTIFUNGAL PROPHYLAXIS, Microbial drug resistance, 3(3), 1997, pp. 283-287
Authors:
SPANIK S
KUKUCKOVA E
PICHNA P
GRAUSOVA S
KRUPOVA I
RUSNAKOVA V
KRALOVICOVA K
KRCHNAKOVA A
MRAZOVA M
LACKA J
KOREN P
STOPKOVA K
NOGOVA J
DEMITROVICOVA A
HELPIANSKA L
KREMERY V
Citation: S. Spanik et al., ANALYSIS OF 553 EPISODES OF MONOMICROBIAL BACTEREMIA IN CANCER-PATIENTS - ANY ASSOCIATION BETWEEN RISK-FACTORS ACID OUTCOME TO PARTICULAR PATHOGEN, Supportive care in cancer, 5(4), 1997, pp. 330-333
Authors:
TRUPL J
KUNOVA A
ORAVCOVA E
PICHNA P
KUKUCKOVA E
GRAUSOVA S
GREY E
SPANIK S
DEMITROVICOVA A
KRALOVICOVA K
LACKA J
KRUPOVA I
SVEC J
KOREN P
KRCMERY V
Citation: J. Trupl et al., RESISTANCE PATTERN OF 2,816 ISOLATES ISOLATED FROM 17,631 BLOOD CULTURES AND ETIOLOGY OF BACTEREMIA AND FUNGEMIA IN A SINGLE CANCER INSTITUTION, Acta oncologica, 36(6), 1997, pp. 643-649
Authors:
SPANIK S
TRUPL J
ILAVSKA I
HELPIANSKA L
DRGONA L
DEMITROVICOVA A
KUKUCKOVA E
STUDENA M
PICHNA P
ORAVCOVA E
RUSNAKOVA V
KOREN P
LACKA J
KRCMERY V
Citation: S. Spanik et al., BACTEREMIA AND FUNGEMIA OCCURRING DURING ANTIMICROBIAL PROPHYLAXIS WITH OFLOXACIN IN CANCER-PATIENTS - RISK-FACTORS, ETIOLOGY AND OUTCOME, Journal of chemotherapy, 8(5), 1996, pp. 387-393